Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer - Part A

Identification of Circulating Biomarkers for Diagnosis and Response to Therapies in Cancer Patients Part A delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. The book covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care, ultimately aiming to enhance patient outcomes and precision medicine strategies.

• Provides a comprehensive overview of circulating biomarkers used in cancer diagnosis, prognosis, and treatment response monitoring
• Discusses the clinical utility of circulating biomarkers in early cancer detection, prognostication, treatment selection, and monitoring therapeutic responses
• Explores the latest technologies and methodologies for the detection, quantification, and analysis of circulating biomarkers in cancer patients